Alain Belanger
5Patents
3h-index
17Co-inventors
54Inventor score
Filing activity: Aug 2, 1984 → Apr 9, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4775660A | Treatment of breast cancer by combination therapy | Emerging Cross-Sectional Technologies | 39 | Expired |
| US6541463B1 | Inhibitors of type 5 and type 3 17&bgr;-hydroxysteroid dehydrogenase and methods for their use | Human Necessities | 15 | Expired |
| US6287834A | Characterization and use of an isolated uridine diphospho-glucuronosyltransferase | Human Necessities | 3 | Expired |
| US11606956B2 | 4-chloroindole-3-acetic acid for controlling unwanted plants | Human Necessities | 0 | Active |
| US10285402B2 | Use of 4-chloroindole-3-acetic acid for controlling unwanted plants | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.